| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.37B | +4.8% |
| R&D Expense | $33.0M | +3.1% |
| SG&A Expense | $632.0M | +5.9% |
| Operating Income | $1.55B | +9.4% |
| Pre-tax Income | $1.16B | +56.1% |
| Income Tax | $281.0M | +53.6% |
| Net Income | $738.0M | +74.1% |
| EPS (Basic) | $6.41 | +80.1% |
| EPS (Diluted) | $6.38 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $764.0M | -16.8% |
| Accounts Receivable | $1.02B | -0.7% |
| Inventory | $1.58B | +9.5% |
| Current Assets | $4.39B | +4.2% |
| Total Assets | $14.27B | +3.1% |
| Current Liabilities | $4.27B | +23.1% |
| Long-term Debt | $5.88B | -4.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.53B | +28.4% |
| Capital Expenditures | $413.0M | +2.5% |
| Investing Cash Flow | -$320.0M | -2566.7% |
| Financing Cash Flow | -$1.36B | +10.8% |
| Free Cash Flow | $1.12B | +41.6% |
| +79.7% |
| Stockholders' Equity |
| $3.00B |
| +8.8% |